Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer.

2017 ◽  
Vol 35 (18_suppl) ◽  
pp. LBA11516-LBA11516 ◽  
Author(s):  
Pedram Razavi ◽  
Bob T. Li ◽  
Wassim Abida ◽  
Alex Aravanis ◽  
Byoungsok Jung ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Detection ◽  
High Intensity ◽  
Tumor Tissue ◽  
De Novo ◽  
Early Cancer ◽  
Metastatic Breast ◽  
Early Cancer Detection ◽  
Driver Mutations ◽  
Castration Resistant Prostate Cancer

LBA11516 Background: ctDNA assays can noninvasively assess tumor burden and biology by identifying tumor-derived somatic alterations. For broad applicability, including early cancer detection, an unprecedented high-intensity approach (ultra-deep sequencing of plasma cell-free DNA (cfDNA) with broad genomic coverage) is needed to address intra-patient and population-level heterogeneity. We present initial results with this approach in patients (pts) with metastatic breast (BC), non-small cell lung (NSCLC), and castration-resistant prostate cancer (CRPC). Methods: Blood and tissue were prospectively collected w/in 6 wks with no intervening therapy change from pts with de novo or progressive cancer. cfDNA and white blood cell (WBC) genomic DNA from each pt were sequenced with a 508-gene panel (2 Mb; >60,000X raw depth). cfDNA variant calling used molecular barcoding for error correction and filtering for WBC variants. Tissue was sequenced using the MSK-IMPACT assay (410 genes, 1.4 Mb, >500X depth) blinded to plasma/WBC sequencing. Variants were classified as clonal or subclonal based on tumor sequencing in BC and NSCLC. Results: Of 161 eligible pts, 124 (39 BC, 41 NSCLC, and 44 CRPC) were evaluable for concordance. In tissue, 864 variants were detected across the 3 tumor types, with 627 (73%) also detected in plasma: single nucleotide variants/indels - 75%, fusions - 67%, and copy number alterations - 58%. In 90% of pts, at least 1 of the variants detected in tumor tissue was also detected in plasma: BC - 97%, NSCLC - 85%, CRPC - 84%. Most actionable mutations detected in tissue were also detected in plasma (54/71, 76%; SNVs only: 28/31, 90%). A subset of driver mutations (eg. in ESR1, PIK3CA, ERBB2, EGFR) were observed in plasma but not tissue. Clonal variants in tissue were more likely to be detected in plasma than subclonal variants (p<.001). Conclusions: This novel, high-intensity ctDNA assay enabled broad detection of genomic variants in plasma at high rates of concordance with corresponding tumor tissue, providing strong evidence for tumor-derivation of these signals. This study will inform development of a high-intensity sequencing approach for early cancer detection.

scholarly journals Small-area data on socioeconomic status and immigrant groups for evaluating equity of early cancer detection and care

2021 ◽  
pp. 1-6
Author(s):  
Ulf Strömberg ◽  
Brandon L. Parkes ◽  
Amir Baigi ◽  
Carl Bonander ◽  
Anders Holmén ◽  
...  
Keyword(s):  
Socioeconomic Status ◽  
Cancer Detection ◽  
Small Area ◽  
Early Cancer ◽  
Early Cancer Detection ◽  
Area Data

Dying To Be Men: Masculinity and Early Cancer Detection Among Nigerian Men

2021 ◽  
pp. 0272684X2110049
Author(s):  
Darlingtina Esiaka ◽  
Candidus Nwakasi ◽  
Kelsey Brodie ◽  
Aaron Philip ◽  
Kalu Ogba
Keyword(s):  
Public Health ◽  
Cancer Detection ◽  
Attachment Styles ◽  
Early Cancer ◽  
Sub Saharan Africa ◽  
Early Cancer Detection ◽  
Anxious Attachment ◽  
Incidence And Mortality ◽  
Nigerian Men ◽  
Sub Saharan

Cancer incidence and mortality in Nigeria are increasing at an alarming rate, especially among Nigerian men. Despite the numerous public health campaigns and education on the importance of early cancer detection in Nigeria, there exist high rate of fatal/advanced stage cancer diagnoses among Nigerian men, even among affluent Nigerian men. However, there is limited information on patterns of cancer screening and psychosocial predictors of early cancer detection behaviors among Nigerian men. In this cross-sectional study, we examined demographic and psychosocial factors influencing early cancer detection behaviors among Nigerian men. Participants (N = 143; Mage = 44.73) responded to survey assessing: masculinity, attachment styles, current and future cancer detection behaviors, and sociodemographic characteristics. We found that among the participants studied, education, masculinity and anxious attachment were significantly associated with current cancer detection behaviors. Additionally, education and anxious attachment were significantly associated with future cancer detection behaviors. Our finding is best served for clinicians and public health professionals, especially those in the field of oncology in Sub-Saharan Africa. Also, the study may be used as a groundwork for future research and health intervention programs targeting men in Sub-Saharan Africa.

Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma

2021 ◽  
Author(s):  
Lin Huang ◽  
Kun Qian
Keyword(s):  
Machine Learning ◽  
Lung Adenocarcinoma ◽  
Cancer Detection ◽  
High Performance ◽  
Large Scale ◽  
Early Cancer ◽  
Early Stage ◽  
Early Cancer Detection ◽  
Ionization Mass ◽  
Efficient Test

Abstract Early cancer detection greatly increases the chances for successful treatment, but available diagnostics for some tumours, including lung adenocarcinoma (LA), are limited. An ideal early-stage diagnosis of LA for large-scale clinical use must address quick detection, low invasiveness, and high performance. Here, we conduct machine learning of serum metabolic patterns to detect early-stage LA. We extract direct metabolic patterns by the optimized ferric particle-assisted laser desorption/ionization mass spectrometry within 1 second using only 50 nL of serum. We define a metabolic range of 100-400 Da with 143 m/z features. We diagnose early-stage LA with sensitivity~70-90% and specificity~90-93% through the sparse regression machine learning of patterns. We identify a biomarker panel of seven metabolites and relevant pathways to distinguish early-stage LA from controls (p < 0.05). Our approach advances the design of metabolic analysis for early cancer detection and holds promise as an efficient test for low-cost rollout to clinics.

Knowledge of Testicular Cancer Risk and Need for Self-Examination in College Students: A Call for Equal Time for Men in Teaching of Early Cancer Detection Techniques

PEDIATRICS ◽  
1984 ◽  
Vol 74 (6) ◽  
pp. 1093-1096
Author(s):  
John M. Goldenring ◽  
Elizabeth Purtell
Keyword(s):  
Testicular Cancer ◽  
Cancer Detection ◽  
Early Cancer ◽  
Early Cancer Detection ◽  
Men And Women ◽  
Equal Time ◽  
Detection Techniques ◽  
The Past ◽  
Knowledge And Practice ◽  
Self Examination

College athletes were surveyed about their knowledge and practice of early cancer detection techniques. Males were almost completely unaware of their risk for testicular cancer (87%). Only 9.6% had been taught testicular self-examination and only half of these by their physician. Six percent actually examined themselves regularly. In comparison, more than 60% of women had been taught breast self-examination (75% by a physician) and about one third were doing regular examinations. More than 90% of the young men and women had been seen by physicians for a physical examination within the past 3 years. Physicians need to begin educating males about testicular cancer and its early detection.

scholarly journals Standards for Plasma and Serum Proteomics in Early Cancer Detection: A Needs Assessment Report from the National Institute of Standards and Technology-National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18–19, 2005

2006 ◽  
Vol 52 (9) ◽  
pp. 1669-1674 ◽  
Author(s):  
Peter E Barker ◽  
Paul D Wagner ◽  
Stephen E Stein ◽  
David M Bunk ◽  
Sudhir Srivastava ◽  
...  
Keyword(s):  
Dna Methylation ◽  
Needs Assessment ◽  
Reference Materials ◽  
Cancer Detection ◽  
National Cancer Institute ◽  
Early Cancer ◽  
Early Cancer Detection ◽  
Assessment Report ◽  
Serum Proteomics

Abstract NIST and the National Cancer Institute cosponsored a workshop on August 18–19, 2005, to examine needs for reference materials for early cancer detection. This meeting focused on standards, methods, assays, reagents, and technologies. Needs for plasma and serum proteomics, DNA methylation, and specimen reference collections were discussed, and recommendations from participants were solicited. This report summarizes the discussion and recommendations for proteomics reference materials.

Sign in / Sign up

Export Citation Format

Share Document